Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Y-Mabs Therapeutics (YMAB)
NASDAQ:YMAB
Y-Mabs Therapeutics (YMAB) Ownership - Who Owns Y-Mabs Therapeutics?
200 Followers
Y-Mabs Therapeutics (YMAB) Ownership Overview
30.00% Insiders
10.39% Mutual Funds
9.86% Other Institutional Investors
49.74% Public Companies and
Individual Investors
The ownership structure of Y-Mabs Therapeutics (YMAB) stock is a mix of institutional, retail and individual investors. Approximately 20.25% of the company’s stock is owned by Institutional Investors, 30.00% is owned by Insiders and 49.74% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 07, 2024 | Thomas Gad Cbo,director | Sold | $64116 |
| Mar 07, 2024 | Vignesh Rajah Svp & Cmo | Sold | $28283 |
| Mar 07, 2024 | Susan Laura Smith Svp & Cco | Sold | $27837 |
| Dec 15, 2023 | Thomas Gad Cbo,director | Sold | $1001000 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $286092 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,955,843 | Institution | 4.47% | 29,337,645 | |
| 1,732,919 | Institution | 3.96% | 25,993,785 | |
| 1,626,430 | Institution | 3.72% | 24,396,450 | |
| 401,386 | Institution | 0.92% | 6,020,790 | |
| 298,303 | Institution | 0.68% | 4,474,545 | |
| 274,933 | Institution | 0.63% | 4,123,995 | |
| 169,440 | Institution | 0.39% | 2,541,600 | |
| 165,496 | Institution | 0.38% | 2,482,440 | |
| 161,416 | Institution | 0.37% | 2,421,240 | |
| 160,050 | Institution | 0.37% | 2,400,750 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,626,430 | Institution | 3.72% | 24,396,450 | |
| 401,386 | Institution | 0.92% | 6,020,790 | |
| 298,303 | Institution | 0.68% | 4,474,545 | |
| 274,933 | Institution | 0.63% | 4,123,995 | |
| 169,440 | Institution | 0.39% | 2,541,600 | |
| 165,496 | Institution | 0.38% | 2,482,440 | |
| 161,416 | Institution | 0.37% | 2,421,240 | |
| 160,050 | Institution | 0.37% | 2,400,750 | |
| 146,197 | Institution | 0.33% | 2,192,955 | |
| 143,155 | Institution | 0.33% | 2,147,325 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,160,761 | Institution | 2.65% | 18,873,974 | |
| 877,673 | Institution | 2.00% | 13,165,095 | |
| 462,334 | Institution | 1.06% | 7,517,551 | |
| 248,390 | Institution | 0.57% | 3,725,850 | |
| 184,907 | Institution | 0.42% | 2,773,605 | |
| 136,893 | Institution | 0.31% | 2,225,880 | |
| 147,425 | Institution | 0.34% | 2,211,375 | |
| 135,746 | Institution | 0.31% | 2,051,122 | |
| 118,922 | Institution | 0.27% | 1,933,672 | |
| 80,345 | Institution | 0.18% | 1,205,175 |
FAQ
Who Owns Y-Mabs Therapeutics (YMAB)?
According to the latest TipRanks data, approximately 9.86% of the company's stock is held by institutional investors, 30.00% is held by insiders, and 49.74% is held by retail investors.
What percentage of Y-Mabs Therapeutics (YMAB) stock is held by institutional investors?
According to the latest TipRanks data, approximately 9.86% of Y-Mabs Therapeutics (YMAB) stock is held by institutional investors.
What percentage of Y-Mabs Therapeutics (YMAB) stock is held by retail investors?
According to the latest TipRanks data, approximately 49.74% of Y-Mabs Therapeutics (YMAB) stock is held by retail investors.
Who owns the most shares of Y-Mabs Therapeutics (YMAB)?
Vanguard owns the most shares of Y-Mabs Therapeutics (YMAB).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.